Van Snick; Jacques

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Snick; Jacques.The latest application filed is for "tgf-b1 specific antibodies and methods and uses thereof".

Company Profile

5.12.17

Van Snick; Jacques - Brussels BE
VAN SNICK; Jacques - Wezembeek-Oppem BE
Van Snick; Jacques - Kraainem BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tgf-b1 Specific Antibodies And Methods And Uses Thereof App 20210403545 - Van Snick; Jacques ; et al.	2021-12-30
TGF- 1 specific antibodies and methods and uses thereof Grant 10,947,303 - Van Snick , et al. March 16, 2	2021-03-16
Tgf-beta 3 Specific Antibodies And Methods And Uses Thereof App 20200392221 - VAN SNICK; Jacques ; et al.	2020-12-17
TGF-.beta.3 specific antibodies and methods and uses thereof Grant 10,723,793 - Van Snick , et al.	2020-07-28
Method For Increasing The Bioavailability Of Inhaled Compounds App 20190160177 - VANBEVER; Rita ; et al.	2019-05-30
Tgf- 1 Specific Antibodies And Methods And Uses Thereof App 20190092847 - Van Snick; Jacques ; et al.	2019-03-28
TGF-.beta.1 specific antibodies and methods and uses thereof Grant 10,035,851 - Van Snick , et al. July 31, 2	2018-07-31
Tgf-beta 3 Specific Antibodies And Methods And Uses Thereof App 20180148501 - VAN SNICK; Jacques ; et al.	2018-05-31
Tgf- 1 Specific Antibodies And Methods And Uses Thereof App 20170137507 - Van Snick; Jacques ; et al.	2017-05-18
TGF-.beta.1 specific antibodies and methods and uses thereof Grant 9,518,112 - Van Snick , et al. December 13, 2	2016-12-13
Method For Increasing The Bioavailability Of Inhaled Compounds App 20160331839 - VANBEVER; Rita ; et al.	2016-11-17
Tgf-beta1 Specific Antibodies And Methods And Uses Thereof App 20150132319 - Van Snick; Jacques ; et al.	2015-05-14
Method For Treatment Or Prophylaxis Of An Infection Using Either An Antibody Which Binds To IL-9 Or An Agent Which Stimulates Production Of Autoantibodies To Interleukin-9 App 20080299073 - Van Snick; Jacques ; et al.	2008-12-04
Recombinant Anti-Interleukin-9 Antibodies App 20080299134 - Reed; Jennifer Lynne ; et al.	2008-12-04
Recombinant anti-interleukin-9 antibodies Grant 7,371,383 - Reed , et al. May 13, 2	2008-05-13
Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases App 20070048261 - Mettens; Pascal ; et al.	2007-03-01
MAGE-A1 peptides presented by HLA class II molecules Grant 7,157,091 - Van Snick , et al. January 2, 2	2007-01-02
Method for making cytokine specific antibodies and uses thereof Grant 7,094,396 - Van Snick , et al. August 22, 2	2006-08-22
Mage-A3 peptides presented by HLA class molecules Grant 6,716,809 - Schultz , et al. April 6, 2	2004-04-06
Method for making cytokine specific antibodies and uses thereof App 20040028650 - Van Snick, Jacques ; et al.	2004-02-12
Recombinant anti-interleukin-9 antibodies App 20030219439 - Reed, Jennifer Lynne ; et al.	2003-11-27
Method of treatment with IL-9 conjugate Grant 6,645,486 - Van Snick , et al. November 11, 2	2003-11-11
Regulation of mononuclear phagocyte stimulation App 20030091533 - Van Snick, Jacques ; et al.	2003-05-15
Methods for inhibiting atherosclerotic plaque formation App 20020164301 - Van Snick, Jacques ; et al.	2002-11-07
Method for regulating IL-10 with IL-9, and applications thereof App 20020136703 - Grohman, Ursula ; et al.	2002-09-26
Method for inhibiting production of IgE by using IL-9 inhibitors Grant 5,246,701 - Dugas , et al. September 21, 1	1993-09-21
Antibodies immunoreactive with the T-cell growth factor, P40 Grant 5,157,112 - Van Snick , et al. October 20, 1	1992-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.